NCT00135837View on ClinicalTrials.gov

Photodynamic Therapy in Occult-Only Lesions (POOL)

PHASE4CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

June 30, 2003

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

Verteporfin for injection

Trial Locations (1)

Unknown

Novartis, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
collaborator

QLT Inc.

INDUSTRY

lead

Novartis

INDUSTRY

NCT00135837 - Photodynamic Therapy in Occult-Only Lesions (POOL) | Biotech Hunter | Biotech Hunter